HealthStream Inc. filed SEC Form 8-K: Leadership Update

false 0001095565 0001095565 2025-03-24 2025-03-24

 

 

 

 

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

 

 

 

 

Registrant’s telephone number, including area code: 615-301-3100

 

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.02          Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On March 24, 2025, William W. Stead, M.D. notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class I director at the Company’s annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting. Dr. Stead’s decision not to stand for re-election and retire from the Board is not the result of any disagreement with the Company.

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.